Piermont Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,830
| Closed | -$103K | – | 236 |
|
|
2018
Q1 | $103K | Sell |
10,830
-1,670
| -13% | -$15.9K | 0.03% | 237 |
|
|
2017
Q4 | $186K | Sell |
12,500
-15,270
| -55% | -$227K | 0.06% | 232 |
|
|
2017
Q3 | $546K | Sell |
27,770
-27,305
| -50% | -$537K | 0.18% | 146 |
|
|
2017
Q2 | $791K | Sell |
55,075
-9,580
| -15% | -$138K | 0.23% | 186 |
|
|
2017
Q1 | $595K | Buy |
+64,655
| New | +$595K | 0.14% | 215 |
|